HICKSVILLE, NY--(NewMediaWire - Sep 19, 2017) - Canbiola, Inc.
(OTC PINK: CANB) announced today that the company has added
Dr. Fratellone to its Medical Advisory Board and engaged Dr.
Fratellone as a distributor for Canbiola products. Dr. Fratellone
is an attending physician at St. Luke's Hospital, Roosevelt
Hospital, and Beth Israel Hospital, and current professor at
University of Bridgeport College of Naturopathic Medicine. In
addition, he bridges East Meets West at the Center of Excellence in
Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your
Blood Type. Dr. Fratellone has appeared on multiple shows, and is
considered an expert in his field as well a visionary. Dr.
Fratellone stated, "As one of the few MDs in the US who is also a
registered herbalist, I believe in traditional and time honored
treatments, but also to look outside of the box; to that end CBD is
certainly part of the future in my opinion with clear benefits to
patients. I look forwarded to working with Canbiola, as well as
educating the public on the vast benefits of CBD through blogs and
speaking engagements."
Marco Alfonsi, Canbiola CEO stated "We are continuing
to execute our plan to strengthen not only our Medical Advisory
Board but also our distribution network. With the addition of Dr.
Fratellone we have added another solid pillar. The company has
already seen the benefits of this strategy with better than
expected results from previously added medical advisors and have no
doubt that this last addition will further grow both sales and
geographically expand our client base."
About Dr. Patrick Fratellone, MD
RH (AHG) FIM
Patrick Fratellone MD is one of the few integrative
cardiologists in the United States. He maintains hospital admitting
privileges at the Mount Sinai Hospitals in NYC. In addition to his
fellowship in cardiovascular diseases he completed a Fellowship of
Integrative Medicine at the University of Arizona under the
direction of Andrew Weil, MD. He is a registered herbalist
(RH) with the American Herbal Guild. Previously, he held
positions as Medical Director of the Fifth Avenue Comprehensive
Medical Group and Regional Director of Cardiology programs for the
Ultrasound Diagnostic Schools. Because of his development of
programs and teaching in these positions, he is recognized as a
forerunner in the field of echocardiography. He was the Medical
Director for the late Robert Atkins, MD at his NYC office on east
55th Street. Not only was Dr. Fratellone his cardiologist, but both
did Dr. Atkins' daily radio show on WOR.
Dr. Fratellone completed his B.S. and B.A. in Biology and
Humanities, respectively, at the State University of Stony Brook
(New York) in 1982. He completed his medical training in London,
where he broadened both his clinical and bedside skills. Dr.
Fratellone finished his medical residency at Lenox Hill Hospital,
in New York City, where he also pursued and completed his
Fellowship in Cardiovascular Disease in 1994. During his three-year
fellowship, he trained at the Nicholas Institute Sports Medicine
and Athletic Trauma at Lenox Hill Hospital in New York City and the
Division of Congenital Heart Diseases at the University of
California at Los Angeles.
Dr. Fratellone hosts an internet web program HouseCalls with
Patrick Fratellone, MD and has hosted a variety of radio programs
on WWRL, WOR, and WBAI. He has also appeared on ABC's "The View
with Barbara Walters," "ABC World News Night with Peter Jennings,"
Fox News Channel and "Good Day New York," as well as numerous radio
talk shows. These include "The Frankie Boyer Show (WBIX in Boston
and regionally syndicated to five other stations): "AWARE Talk
Radio," hosted by LaVeda Peterlin and distributed to more than 400
stations nationwide. Dr. Fratellone is a regular contributor to
Radius Magazine, The Bottom Line, Instinct Magazine, Healthy Woman
and is a Medical Adviser to Life Extension Magazine.
His interview with the BBC ten years ago has been re-released
and edited to include his opinions on new dietary lifestyles as
opposed to diet fads. He recently appeared on FOX FILES with
Actress Jennifer Esposito discussing Celiac Disease. Dr. Fratellone
also is a regular instructor for the Sylvan Institute of Botanical
Medicine.
Dr. Fratellone is the author of You're on the Air with Dr.
Fratellone-Answers to Questions Most Frequently Asked About
Vitamins and Supplements for the Heart (to order, go
to www.rpgassoc.com) as well as numerous articles on
congenital heart disease published in medical journals such as
Chest, American Heart Journal and Catherization Review.
Dr. Fratellone is an attending physician at St. Luke's Hospital,
Roosevelt Hospital and Beth Israel Hospital in New York City. Dr.
Fratellone is the only integrative physician in New York City with
active hospital admitting privileges at three city hospitals. He is
a member of the American College of Cardiology and the American
College of Physicians.
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
The company's focus is in the sale of a variety of Cannabidiol
(CBD) based products derived from legally imported Hemp. Canbiola
is in the process of developing its own line of proprietary
products as well as seeking synergistic value through acquisitions
in the CBD and the medical cannabis industry. The company has
already launched several products found at www.canbiola.com.
Cannabis is currently federally illegal and has been legalized for
medical purposes in varying forms in only a limited number of
states.
The company also owns two technological solutions, "WRAPmail"
(US Patent 8,572,275), which turns traditional email into a
powerful marketing and branding tool, and "Prosperity Systems" and
the "Bullseye" platform of document management and compliance
targeted at broker dealers, public companies, and governmental
agencies providing a flawless all-in-one solution for document
management, retention and compliance.
Forward looking statements and risks and
uncertainties
Matters discussed in this press release contain forward-looking
statements. The words "anticipate," "believe," "estimate," "may,"
"intend," "expect," and similar expressions identify such
forward-looking statements. Expected results, actual results,
performance, or achievements could differ materially from those
contemplated, expressed, or implied by the forward-looking
statements contained herein. Forward-looking statements are subject
to a number of risks and uncertainties, including but not limited
to, risks and uncertainties associated with, among other things,
the impact of economic, competitive, and other factors affecting
our operations, markets, products, and performance. The matters
discussed herein should not be construed in any way, shape or
manner of our future financial condition or stock price. We do not
undertake to update any statement should actual result differ from
the forward-looking statement.
For more complete information regarding our business
at Canbiola.
Twitter
Facebook